Published in Cancer Weekly, September 1st, 2009
"Quality of life (QoL) and bladder, intestinal, and Sexual dysfunctions were evaluated with the Functional Assessment of Cancer Therapy-Cervix (FACT-Cx). were grouped according to the type of RH: group I, class II RH and group 2, class III nerve-sparing RH (NSRH). Of 157 women included in the Study, 127 filled Out file questionnaire. Overall, QoL score assessed with the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.